Abstract
Treatment of type 1 diabetes mellitus (T1D) in children and adolescents is complex and a challenge for the children and adolescents themselves, their families, and their whole environment (schools/kindergartens). The aim of the diabetes therapy is to achieve near-normoglycemic glucose values and to prevent acute and chronic complications. Further aims are normal development, inclusion, flexibility in everyday life, and a high quality of live. Apart from newer insulin analogues, diabetes technology has changed and improved diabetes therapy and the quality of life of affected families. The usage of insulin pumps—continuous insulin infusion, continuous subcutaneous glucose monitoring, and automated insulin dosing (AID) has led to significant improvement in metabolic control, a reduction of severe hypoglycemia and diabetic ketoacidosis. Diabetes technology is constantly evolving and necessitates comprehensive continuing education of the families, the school/kindergarten teams, as well as the multidisciplinary team of healthcare professionals. The intention is a reduction of glycemic variability and a better long-term outcome in young people with T1D. AID is increasingly becoming the therapy of choice in children and adolescents with T1D. Further innovations in diabetes technology can be expected for the near future.